First liver cases with EndoDrill GI performed in the USA
The cancer diagnostics company BiBBInstruments AB (“BiBB” or the “Company”), the developer of EndoDrill® – the world’s first market-cleared powered biopsy instrument for endoscopy – announces that Dr. Mohammed Barawi, Medical...
BiBB participated in clinical cases with EndoDrill GI in Germany for the indication EUS-guided liver biopsy
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of EndoDrill®, the world’s first market-cleared, powered biopsy instrument for endoscopy, announces that BiBB participated in clinical cases involving...
BiBB receives first order for EndoDrill GI from a university hospital in the US
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of EndoDrill®, the world’s first market-cleared, electric-driven biopsy instrument for endoscopy, announces that the first order for EndoDrill® GI...
BiBBInstruments announces final outcome of rights issue
BiBBInstruments AB (“BiBB” or the “Company”) today announces the final outcome of the rights issue of units of approximately SEK 36.5 million that was announced by the Company on 8 November...
BiBBInstruments announces preliminary outcome of rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA,...
Clinical evaluation at Karolinska University Hospital is progressing
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of EndoDrill®, the world’s first market-cleared, electric-driven biopsy instrument for endoscopy, announces that the Company’s clinical evaluation is proceeding...
Well-executed clinical introduction of EndoDrill® GI at Sahlgrenska University Hospital in Sweden
The cancer diagnostics company BiBBInstruments AB (“BiBB” and the “Company”), the developer of EndoDrill®, the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first clinical tissue sampling procedures...
BiBB has initiated a collaboration with Swedish contract manufacturer Cenova
The cancer diagnostics company BiBBInstruments AB (“BiBB” and the “Company”), the developer of EndoDrill®, the world’s first market-cleared electric-driven biopsy instrument for endoscopy, informs that the Company has initiated a collaboration...
Impressive US Clinical Case Series presented at ACG 2024 in Philadelphia
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that a recently published clinical case series in...
BiBB receives an Intention to Grant for EndoDrill patent in China
The cancer diagnostics company BiBBInstruments AB (“BiBB”), the developer of the world’s first market-cleared electric-driven biopsy instrument for endoscopy, today announces that the Company has received an Intention to Grant from...
New Peer-Reviewed Clinical Case Series in the U.S. Shows 100% Diagnostic Accuracy with EndoDrill GI
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first eight patient cases using EndoDrill®...
EndoDrill GI sparks interest at the 7th Nordic EUS Meeting in Copenhagen
The cancer diagnostics company BiBBInstruments AB (“BiBB or the “Company”), the developer of the world’s first market-cleared electric-driven biopsy instrument for endoscopy, announces that the Company, for the first time, has...